搜尋結果
4 天前 · Initiation of metformin hydrochloride oral solution in patients with an eGFR between 30 to 45 mL/minute/1.73 m 2 is not recommended. In patients taking metformin hydrochloride oral solution whose eGFR later falls below 45 mL/min/1.73 m 2 , assess the benefit risk of continuing therapy.
19 小時前 · Metformin use was compared among cases with MPN and an age- and sex-matched control group from the Danish general population (3,816 cases and 19,080 controls). The researchers found that 7.0 and 8.2 percent of cases and controls were categorized as ever-users of metformin, respectively (odds ratio [OR] for MPN, 0.84; adjusted OR for MPN, 0.70).
13 小時前 · People who use metformin are less likely to develop a group of rare blood cancers over time. The corresponding study was published in Blood Advances. Metformin is a drug used to treat high blood sugar in people with type 2 diabetes. Studies suggest that it may hold potential against cancer- both as a preventative agent and as a therapeutic when used alongside immunotherapy, although further ...
5 天前 · Metformin is of great focus because of its high safety, low side effects, and various effects other than lowering blood sugar, such as anti-inflammation, anti-tumor, and anti-aging. Studies have shown that metformin has a modulating effect on the composition and function of the intestinal microbiota other than acting on the liver.
19 小時前 · Cite this article Yi, Y., Kwon, E., Yun, G. et al. Author Correction: Impact of metformin on cardiovascular and kidney outcome based on kidney function status in type 2 diabetic patients: a ...
其他人也問了
What is metformin hydrochloride oral solution?
Are metformin HCl tablets safe for patients with Type 2 diabetes mellitus?
What is the structural formula of metformin hydrochloride?
Can metformin hydrochloride cause hypoglycemia?
2 天前 · Many studies have shown that metformin helps to treat the life-shortening diseases that are the leading causes of death in North America today — diabetes, heart disease, several types of cancers, kidney disease, liver disease, obesity and others (Front Endocrinol, August 4, 2021;12)., August 4, 2021;12).
3 天前 · Metformin use was found to significantly lower the likelihood of developing myeloproliferative neoplasms (MPN), which may also be useful in preventing the development of additional cancers, according to findings from a meta-analysis published in Blood Advances.
